109 related articles for article (PubMed ID: 9808853)
1. Effects of vasoactive agents in healthy and diseased human saphenous veins.
Rizzi A; Quaglio D; Vasquez G; Mascoli F; Amadesi S; Calò G; Regoli D; Zamboni P
J Vasc Surg; 1998 Nov; 28(5):855-61. PubMed ID: 9808853
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ mobilization in saphenous vein smooth muscle cells derived from patients with primary varicosity.
Schuller-Petrovic S; Stessel H; Brunner F
Eur J Clin Invest; 2002 Sep; 32(9):649-56. PubMed ID: 12486863
[TBL] [Abstract][Full Text] [Related]
3. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness of human varicose saphenous veins to vasoactive agents.
Brunner F; Hoffmann C; Schuller-Petrovic S
Br J Clin Pharmacol; 2001 Mar; 51(3):219-24. PubMed ID: 11298067
[TBL] [Abstract][Full Text] [Related]
5. Functional adaptation of venous smooth muscle response to vasoconstriction in proximal, distal, and varix segments of varicose veins.
Raffetto JD; Qiao X; Beauregard KG; Tanbe AF; Kumar A; Mam V; Khalil RA
J Vasc Surg; 2010 Apr; 51(4):962-71. PubMed ID: 20347695
[TBL] [Abstract][Full Text] [Related]
6. Defining the differential sensitivity to norepinephrine and angiotensin II in the ovine uterine vasculature.
Rosenfeld CR; DeSpain K; Liu XT
Am J Physiol Regul Integr Comp Physiol; 2012 Jan; 302(1):R59-67. PubMed ID: 22031783
[TBL] [Abstract][Full Text] [Related]
7. Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1.
Ballew JR; Watts SW; Fink GD
J Pharmacol Exp Ther; 2001 Feb; 296(2):345-50. PubMed ID: 11160616
[TBL] [Abstract][Full Text] [Related]
8. Role of endothelium and nitric oxide in the in vitro response of equine colonic venous rings to vasoconstrictor agents.
Moore RM; Venugopalan CS; Sedrish SA; Holmes EP
Am J Vet Res; 1997 Oct; 58(10):1145-51. PubMed ID: 9328669
[TBL] [Abstract][Full Text] [Related]
9. The human saphenous vein in pharmacology: effect of a new micronized flavonoidic fraction (Daflon 500 mg) on norepinephrine induced contraction.
Juteau N; Bakri F; Pomies JP; Foulon C; Rigaudy P; Pillion G; Lange G; Genre O; Cron JP
Int Angiol; 1995 Sep; 14(3 Suppl 1):8-13. PubMed ID: 8919257
[TBL] [Abstract][Full Text] [Related]
10. Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins.
Raffetto JD; Khalil RA
J Vasc Surg; 2011 Aug; 54(2):489-96. PubMed ID: 21498026
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostaglandin synthesis does not affect contractile responses to noradrenaline, serotonin, angiotensin II nor endothelin-1 in human forearm isolated veins.
Chin JP; Hurlston RM; Dart AM
Br J Clin Pharmacol; 1993 Oct; 36(4):303-7. PubMed ID: 12959307
[TBL] [Abstract][Full Text] [Related]
12. Characterization of endothelin receptors in human varicose veins.
Barber DA; Wang X; Gloviczki P; Miller VM
J Vasc Surg; 1997 Jul; 26(1):61-9. PubMed ID: 9240323
[TBL] [Abstract][Full Text] [Related]
13. Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein.
Cracowski JL; Stanke-Labesque F; Sessa C; Hunt M; Chavanon O; Devillier P; Bessard G
Can J Physiol Pharmacol; 1999 Oct; 77(10):770-6. PubMed ID: 10588481
[TBL] [Abstract][Full Text] [Related]
14. The effect of stress and in vivo vasoactive intestinal peptide (VIP) treatment on the response of isolated rat aorta to norepinephrine, angiotensin II and vasopressin, and adventitial mast cells.
Tunçel N; Erkasap N; Sahintürk V
Stress; 2000 Nov; 3(4):299-308. PubMed ID: 11342395
[TBL] [Abstract][Full Text] [Related]
15. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.
Camarda V; Rizzi A; Calò G; Gendron G; Perron SI; Kostenis E; Zamboni P; Mascoli F; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):141-9. PubMed ID: 11819032
[TBL] [Abstract][Full Text] [Related]
16. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
17. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein.
Yagi S; Takata S; Kiyokawa H; Yamamoto M; Noto Y; Ikeda T; Hattori N
Diabetes; 1988 Aug; 37(8):1064-7. PubMed ID: 3292327
[TBL] [Abstract][Full Text] [Related]
18. Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses.
Park TC; Harker CT; Edwards JM; Moneta GL; Taylor LM; Porter JM
J Vasc Surg; 1993 Jul; 18(1):61-8; discussion 68-9. PubMed ID: 8326660
[TBL] [Abstract][Full Text] [Related]
19. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine responses in rat renal and femoral veins are reinforced by vasoconstrictor prostanoids.
de Souza Rossignoli P; Yamamoto FZ; Pereira OC; Chies AB
Vascul Pharmacol; 2015 Sep; 72():93-100. PubMed ID: 26141930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
